Table 5. Ablation phenotypes with and without reduced EGFR.
| Genotype | Days recovered | Hub/GC/CySC | Hub/GC | Hub/CySC | Hub only | No hub |
|---|---|---|---|---|---|---|
| C587-Gal4; UAS-Grim/+; Tub-Gal80ts | 0 | < 1%(n = 2/213) | 93%(n = 197/213) | < 1%(n = 1/213) | 4%(n = 8/213) | 2%(n = 5/213) |
| C587-Gal4; UAS-Grim/ EgfrF24; Tub-Gal80ts | 0*,§,ns | 3%(n = 3/108) | 87%(n = 94/108) | 0%(n = 0/108) | 8%(n = 9/108) | 2%(n = 2/108) |
| C587-Gal4; UAS-Grim/+; Tub-Gal80ts | 7 | 80%(n = 180/225) | 4%(n = 9/225) | 1%(n = 3/180) | 13%(n = 29/225) | 2%(n = 4/225) |
| C587-Gal4; UAS-Grim/ EgfrF24; Tub-Gal80ts | 7†,§,**** | 45%(n = 64/142) | 20%(n = 28/142) | < 1%(n = 1/142) | 34%(n = 48/142) | < 1%(n = 1/142) |
| C587-Gal4; UAS-Grim/+; Tub-Gal80ts | 14 | 81%(n = 123/151) | 1%(n = 2/151) | 2%(n = 3/151) | 15%(n = 22/151) | < 1%(n = 1/151) |
| C587-Gal4; UAS-Grim/ EgfrF24; Tub-Gal80ts | 14‡,§,*** | 55%(n = 64/116) | 6%(n = 7/116) | 3%(n = 3/116) | 33%(n = 39/116) | 3%(n = 3/116) |
*
Compared with C587-Gal4; UAS-Grim/+; Tub Gal80ts at 0 days recovered.
†
Compared with C587-Gal4; UAS-Grim/+; Tub Gal80ts at 7 days recovered.
‡
Compared with C587-Gal4; UAS-Grim/+; Tub Gal80ts at 14 days recovered.
§
Chi Square Test: ***p < 0.001, ****p < 0.0001, ns = not significant.